Not every peptide sits in the same regulatory box. Some have gone through the full FDA approval process for specific uses. Others are investigational, meaning they have been studied but not approved. A few exist mostly in research settings and cannot be legally sold to consumers at all. When you compare providers, that distinction matters more than any marketing copy.
Here is the practical version. The evidence a compound has accumulated helps determine its legal status, and its legal status determines whether a licensed pharmacy can put it in your hands with a valid prescription. Let us walk through four peptides that come up often.
Approved versus investigational
Semaglutide and tirzepatide are FDA-approved GLP-1 medications sold under brand names by their manufacturers. Approval means the agency reviewed clinical data for defined uses. That is the strongest regulatory footing a drug can have, and it is why these two are the most straightforward to obtain legitimately through a prescription.
Tesamorelin is also FDA-approved, though for a narrower indication than the GLP-1 drugs. It has an approved brand product behind it.
Semax is different. It is not FDA-approved in the United States. Most of its clinical literature comes from outside the country, and it remains investigational here. That changes what a legitimate provider can and cannot offer you.
How each becomes legitimately available
A licensed pharmacy filling a valid prescription from a clinician is the only purchase channel worth considering. For the approved products, that can mean a brand-name manufactured drug. In some cases it can mean a compounded version prepared by a 503A pharmacy or a 503B outsourcing facility, subject to current FDA rules on what may be compounded and when.
Compounding availability is not static. It depends on drug shortage status, the specific compound, and evolving guidance. A compound being available today does not guarantee it will be next year. Ask a provider directly what they dispense, from what type of pharmacy, and whether it is a brand product or a compounded preparation.
What drives the cost
Price differences come from real factors, not just markup. Brand-name approved drugs carry their own pricing and may or may not be covered by insurance depending on the indication and your plan. Compounded preparations are priced differently and are generally not covered the same way. The pharmacy type, the compound itself, and whether a telehealth consultation is bundled all move the number.
For a compound like semax that lacks FDA approval, be skeptical of any consumer offer at all. Low prices from unregulated sources usually signal that you are not dealing with a licensed pharmacy.
Vetting a provider
A few concrete checks separate legitimate providers from the rest.
- They require a consultation with a licensed clinician before prescribing, not just a checkout form.
- They dispense through a named, licensed pharmacy, and they will tell you whether it is a 503A or 503B facility.
- They are clear about whether you are getting a brand product or a compounded preparation.
- They do not promise specific health outcomes or push research-use-only material.
The uneven evidence base across peptides is exactly why this homework matters. Two approved drugs, one approved for a narrower use, and one not approved at all can all appear in the same online catalog. Their legal paths to you are not the same.
This is general information, not medical advice. Decisions about whether any of these compounds fit your situation belong with a licensed clinician who knows your history.